Expression of Human ApoAII in Transgenic Rabbits Leads to Dyslipidemia | Zendy

Tomonari Koike | Zendy; Shuji Kitajima | Zendy; Ying Yu | Zendy; Ying Li | Zendy; Kazutoshi Nishijima | Zendy; Enqi Liu | Zendy; Huijun Sun | Zendy; Ahmed Bilal Waqar | Zendy; Nobumitsu Shibata | Zendy; Tomoriho Inoue | Zendy; Yao Wang | Zendy; Bo Zhang | Zendy; Junji Kobayashi | Zendy; Masatoshi Morimoto | Zendy; Keijiro Saku | Zendy; Teruo Watanabe | Zendy; Jianglin Fan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Expression of Human ApoAII in Transgenic Rabbits Leads to Dyslipidemia

Author(s) -

Tomonari Koike,

Shuji Kitajima,

Ying Yu,

Ying Li,

Kazutoshi Nishijima,

Enqi Liu,

Huijun Sun,

Ahmed Bilal Waqar,

Nobumitsu Shibata,

Tomoriho Inoue,

Yao Wang,

Bo Zhang,

Junji Kobayashi,

Masatoshi Morimoto,

Keijiro Saku,

Teruo Watanabe,

Jianglin Fan

Publication year - 2009

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.109.190264

Subject(s) - medicine , endocrinology , very low density lipoprotein , apolipoprotein b , hyperlipidemia , dyslipidemia , lipoprotein , genetically modified mouse , cholesterol , transgene , chemistry , biochemistry , obesity , diabetes mellitus , gene

Apolipoprotein AII (apoAII) is the second major apolipoprotein in high-density lipoprotein (HDL). However, the physiological functions of apoAII in lipoprotein metabolism have not been fully elucidated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research